N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as
申请人:Eli Lilly and Company
公开号:US05283361A1
公开(公告)日:1994-02-01
This invention relates to N-hydroxy-N-[3-[2-(4'-halophenylthio)phenyl]prop-2-enyl]ureas, formulations containing those compounds and methods of using such compounds as 5-lipoxygenase inhibiting agents.